Press Releases

Date	Title
3/21/22	Pulse Biosciences Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call for March 31, 2022
2/15/22	Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer
2/8/22	Pulse Biosciences Provides an Update on Recent FDA 510(k) Submission
2/1/22	Pulse Biosciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
1/11/22	Pulse Biosciences Announces Preliminary Fourth Quarter and Full Year 2021 Financial and Operational Results
11/18/21	Pulse Biosciences to Participate in the Stephens Annual Investment Conference
11/15/21	Pulse Biosciences Reports Third Quarter 2021 Financial Results
11/4/21	Pulse Biosciences to Present at the Stifel 2021 Virtual Healthcare Conference
11/2/21	Pulse Biosciences Schedules Third Quarter 2021 Financial Results Conference Call for November 15, 2021
10/5/21	Pulse Biosciences Appoints Laureen DeBuono to Its Board of Directors

Keyword Search